cerebral arterial disease
cerebral arterial disease
Explore linked clinical trials. Standard reference: MONDO:000669358 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy | Nutritional and Metabolic Diseases, amyloidosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, metabolic disease, nervous system disorder, proteostasis deficiencies, vascular disorder | Recruiting | Phase 3 | 2026-09-30 | NCT07250035 | |
| A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy | Nutritional and Metabolic Diseases, amyloidosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, metabolic disease, nervous system disorder, proteostasis deficiencies, vascular disorder | Active, not recruiting | Phase 2 | 2026-09-18 | NCT06393712 | |
| Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD) | Acute Ischemic Stroke, Anterior Cerebral Artery Syndrome, Cardioembolic Stroke, Embolic Stroke, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Vasogenic Cerebral Edema, anterior cerebral artery infarction, brain disorder, brain edema, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, intracranial arterial disease, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Not stated | 2026-09-14 | NCT07013396 | |
| Florida Cerebrovascular Disease Biorepository and Genomics Center | Arterial Occlusive Diseases, Cardiovascular Abnormalities, Cerebral Small Vessel Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Embolism and Thrombosis, Fistula, Hemorrhage, Hypoxia, Hypoxia, Brain, Infarction, Intracranial Embolism and Thrombosis, Intracranial Hemorrhages, Leukoaraiosis, Leukoencephalopathies, Moyamoya disease, Necrosis, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, Subarachnoid Hemorrhage, Aneurysmal, Thromboembolism, Vascular Fistula, arteriosclerosis disorder, arteriovenous hemangioma/malformation, brain disorder, brain hypoxia - ischemia, brain infarction, brain ischemia, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, congenital arteriovenous fistula, dementia, fibromuscular dysplasia, hereditary disease, intracerebral hemorrhage, intracranial arterial disease, intracranial arteriosclerosis, intracranial thrombosis, ischemic disease, ischemic stroke, nervous system disorder, psychiatric disorder, reversible cerebral vasoconstriction syndrome, stroke disorder, subarachnoid hemorrhage, transient ischemic attack, vascular dementia, vascular disorder, vascular malformation | Active, not recruiting | Not stated | 2026-09-03 | NCT05491980 | |
| Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy. | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Amyloid Angiopathy, Familial, Cerebral Small Vessel Diseases, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, amyloidosis, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, dementia, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, intracranial arterial disease, ischemic disease, metabolic disease, nervous system disorder, proteostasis deficiencies, psychiatric disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-09-01 | NCT06933212 | |
| Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, dementia, disease, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-08-31 | NCT06938100 | |
| Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments | Arterial Occlusive Diseases, Moyamoya disease, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-08-28 | NCT07144930 | |
| Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project) | Arterial Occlusive Diseases, Moyamoya disease, Nutritional and Metabolic Diseases, amyloidosis, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, metabolic disease, nervous system disorder, proteostasis deficiencies, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-08-28 | NCT06714097 | |
| 5T MRI and Metabolomics-Based Hemorrhage Risk Prediction in Moyamoya Disease | Arterial Occlusive Diseases, Hemorrhage, Intracranial Hemorrhages, Moyamoya disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2026-08-24 | NCT07781579 | |
| Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease. | Arterial Occlusive Diseases, Moyamoya disease, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-08-13 | NCT07762547 | |
| Retina is a Marker for Cerebrovascular Heath | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1, cerebral infarction, cerebrovascular disorder, dementia, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-03 | NCT04753970 | |
| Application of Extended Reality (XR)-Assisted Computed Tomography (CT)-Guided Localization in Extracranial-intracranial (EC-IC) Bypass Surgery | Arterial Occlusive Diseases, Moyamoya disease, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Recruiting | Not stated | 2026-07-23 | NCT07711457 | |
| Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA) | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Amyloid Angiopathy, Familial, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemorrhage, Intracranial Hemorrhages, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, amyloidosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebrovascular disorder, cognitive disorder, dementia, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, intracerebral hemorrhage, intracranial arterial disease, metabolic disease, nervous system disorder, proteostasis deficiencies, psychiatric disorder, vascular disorder | Active, not recruiting | Phase 2 | 2026-07-21 | NCT07716865 | |
| Safety and Efficacy of Edaravone Dexborneol Sublingual Tablets for Blood-Brain Barrier Dysfunction in CADASIL | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, dementia, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Not yet recruiting | Phase 2 | 2026-07-09 | NCT07692399 | |
| Neurologic Stem Cell Treatment Study | Alzheimer disease, Brain Damage, Chronic, Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, Cerebral Small Vessel Diseases, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniocerebral Trauma, Diabetes Complications, Disease Attributes, Frontotemporal Lobar Degeneration, Hemorrhage, Infarction, Intracranial Hemorrhages, Lewy Body Variant of Alzheimer Disease, Lewy body dementia, Necrosis, Nerve Degeneration, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, autonomic nervous system disorder, basal ganglia disorder, brain disorder, brain infarction, brain injury, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, cognitive disorder, cranial nerve neuropathy, dementia, dementia pugilistica, demyelinating disease, diabetes mellitus, diabetic neuropathy, endocrine system disorder, eye disorder, frontotemporal dementia, hereditary disease, hypotensive disorder, immune system disorder, injury, intracerebral hemorrhage, intracranial arterial disease, ischemic disease, metabolic disease, motor neuron disorder, movement disorder, multiple sclerosis, multiple system atrophy, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, parkinsonian disorder, peripheral nervous system disorder, peripheral neuropathy, primary dysautonomia, progressive supranuclear palsy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, stroke disorder, synucleinopathy, tauopathy, vascular dementia, vascular disorder | Recruiting | Not applicable | 2026-06-26 | NCT02795052 | |
| Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2 | Cardiovascular Abnormalities, Cavernous Sinus Syndromes, Central Nervous System Vascular Malformations, Cerebral Small Vessel Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infarction, Necrosis, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, cavernous hemangioma, central nervous system disorder, central nervous system malformation, cerebral arterial disease, cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1, cerebral infarction, cerebrovascular disorder, dementia, hemangioma, hematologic disorder, hemorrhagic disease, hereditary disease, intracranial arterial disease, ischemic disease, neoplasm, nervous system disorder, stroke disorder, vascular cancer, vascular dementia, vascular disorder, vascular hemostatic disease, vascular malformation | Not yet recruiting | Not applicable | 2026-06-16 | NCT07650110 | |
| Roods vs PNF for Upper Limb Function in Acute MCA Stroke | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, intracranial arterial disease, ischemic disease, middle cerebral artery infarction, nervous system disorder, stroke disorder, vascular disorder | Enrolling by invitation | Not applicable | 2026-06-01 | NCT07616622 | |
| Long-term Prospective Study of Korean CADASIL Patients | Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Leukoencephalopathies, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, dementia, hereditary disease, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular dementia, vascular disorder | Recruiting | Not stated | 2026-05-14 | NCT07497867 | |
| Translational Immunodiagnostics in Stroke (TrImS) | Acute Ischemic Stroke, Arrhythmias, Cardiac, Cardioembolic Stroke, Embolic Stroke, Embolism, Embolism and Thrombosis, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anterior cerebral artery infarction, atrial fibrillation, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, heart disorder, hemorrhagic stroke, intracranial arterial disease, ischemic disease, ischemic stroke, middle cerebral artery infarction, nervous system disorder, stroke disorder, thrombotic disease, transient ischemic attack, vascular disorder | Recruiting | Not stated | 2026-05-11 | NCT05300997 | |
| Remimazolam Consumption: TCI vs. Manual Infusion | Arterial Occlusive Diseases, Moyamoya disease, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Recruiting | Not applicable | 2026-04-23 | NCT07377695 | |
| Family-Based Moyamoya Susceptibility and Early Detection | Arterial Occlusive Diseases, Moyamoya disease, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Recruiting | Not stated | 2026-04-08 | NCT07517354 | |
| Neurosurgical Outcome Network | Aneurysm, Arterial Occlusive Diseases, Cardiovascular Abnormalities, Chiari malformation type I, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniocerebral Trauma, Craniofacial Pain, Drug Resistant Epilepsy, Dyskinesias, Facial Pain, Hematoma, Hematoma, Epidural, Spinal, Hematoma, Subdural, Hemorrhage, Intracranial Hemorrhage, Traumatic, Intracranial Hemorrhages, Moyamoya disease, Muscle Hypertonia, Muscle Spasticity, Neurologic Manifestations, Neuromuscular Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stomatognathic Diseases, Tremor, anxiety disorder, arteriovenous hemangioma/malformation, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebrovascular disorder, cranial nerve neuropathy, depressive disorder, dystonic disorder, epilepsy, facial nerve disorder, facial neuralgia, hydrocephalus, injury, intracranial arterial disease, mouth disorder, movement disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, nervous system injury, neuralgia, neuromuscular disease, normal pressure hydrocephalus, obsessive-compulsive disorder, peripheral nervous system disorder, psychiatric disorder, subarachnoid hemorrhage, trigeminal nerve disorder, trigeminal neuralgia, vascular disorder, vascular malformation | Recruiting | Not stated | 2026-03-30 | NCT06724029 | |
| SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA) | Nutritional and Metabolic Diseases, amyloidosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, metabolic disease, nervous system disorder, proteostasis deficiencies, vascular disorder | Recruiting | Not stated | 2026-03-30 | NCT04204642 | |
| Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anterior cerebral artery infarction, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, intracranial arterial disease, ischemic disease, nervous system disorder, stroke disorder, vascular disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-03-04 | NCT07449910 | |
| Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy | Nutritional and Metabolic Diseases, amyloidosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, metabolic disease, nervous system disorder, proteostasis deficiencies, vascular disorder | Enrolling by invitation | Phase 2 | 2026-02-24 | NCT06421532 |